Improvements in fibrosis were observed in up to 55% of patients, although these results did not consistently reach statistical significance
An analysis of a large US database showed that, in individuals on RAASi therapy who developed hyperkalemia, the dose was titrated down in 1 of 5 hyperkalemic events and was discontinued in another 1 of 5 hyperkalemic events [26]
Many locations on the body are possible for subcutaneous injections, like the abdomen, thighs, or upper arms
Aim for at least 2025g of high-quality protein per meal
Spirulinas unique blue pigment, phycocyanin, has been independently shown to produce peptides with significant DPP-IV inhibitory activity (Grativol et al., 2020)
In the recently published BARI-OPTIMISE double-blind, placebo-controlled trial, 70 patients post-SG or RYGB who were tested and found to have insufficient GLP-1 response to meal stimulation were randomized to receive liraglutide (3 mg/day) or placebo, in addition to lifestyle interventions [49]